Logotype for VolitionRX Ltd

VolitionRX (VNRX) Proxy Filing summary

Event summary combining transcript, slides, and related documents.

Logotype for VolitionRX Ltd

Proxy Filing summary

26 Jan, 2026

Executive summary

  • Special Meeting scheduled for March 31, 2026, to vote on two key proposals: issuing shares exceeding 20% of outstanding stock to Lind Global Asset Management XII LLC and authorizing a reverse stock split at a ratio between 1-for-5 and 1-for-20, at the board's discretion.

  • Board unanimously recommends voting in favor of both proposals, citing compliance with NYSE American Rule 713 and contractual obligations.

  • Voting can be conducted online, by phone, mail, or in person, with a record date of February 9, 2026.

Voting matters and shareholder proposals

  • Proposal 1 seeks approval to issue additional shares exceeding 20% of outstanding stock to Lind Global Asset Management XII LLC, potentially diluting existing shareholders but required for compliance with NYSE rules.

  • Proposal 2 requests authorization for a reverse stock split at a ratio between 1-for-5 and 1-for-20, to be implemented at the board's discretion, primarily to improve marketability and maintain exchange listing.

  • Both proposals require a majority vote of shares present or represented by proxy; abstentions count as votes against, broker non-votes have no effect.

Board of directors and corporate governance

  • Board of directors has full discretion to implement or abandon the reverse stock split even after shareholder approval.

  • No director or executive officer has a substantial interest in the reverse stock split beyond that of all shareholders.

Partial view of Summaries dataset, powered by Quartr API
AI can get things wrong. Verify important information.
All investor relations material. One API.
Learn more